A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis

Clinical Cancer Research

Volumn 12, Issue 18, 2006, Pages 5298-5304

  Degenhardt, Kurt ^a   White, Eileen ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; BORTEZOMIB; PACLITAXEL; PROTEIN BAK; PROTEIN BAX; PROTEIN P53; TAXANE DERIVATIVE;

APOPTOSIS; BODY REGIONS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; CHEMICAL ANALYSIS; EPITHELIUM CELL; EPITHELIUM TUMOR; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENETIC EPISTASIS; GENETIC SCREENING; GENETIC SELECTION; GENOTYPE; HETEROZYGOSITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY EPITHELIUM; MICROENVIRONMENT; MOLECULAR GENETICS; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EPISTASIS, GENETIC; EPITHELIAL CELLS; FEMALE; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY; MALE; MICE; MODELS, ANIMAL; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 33745960644     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0439     Document Type: Review

References (42)

1. White E. Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 2001;20:7836-46.
2. White E. Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis. Cell Death Differ 2006;13:1371-7.
3. Berk AJ. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005;24:7673-85.
4. Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003;24:159-69.
5. Hahn W, Weinberg R. Rules for making human tumor cells. N Engl J Med 2002;347:1593-603.
6. Debbas M, White E. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev 1993;7:546-54.
7. Degenhardt K, Sundararajan R, Lindsten T, Thompson CB, White E. Bax and Bak independently promote cytochrome c release from mitochondria. J Biol Chem 2002;277:14127-34.
8. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 1996;10:461-77.
9. Lin H-JL, Eivner V, Prendergast GC, White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 1995;15:4536-44.
10. Sabbatini P, Chiou S-K, Rao L, White E. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol 1995;15:1060-70.
11. Sabbatini P, Han JH, Chiou S-K, Nicholson D, White E. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ 1997;8:643-53.
12. Sabbatini P, Lin J, Levine AJ, White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995;9:2184-92.
13. Sakamuro D, Eviner V, Elliot KJ, Showe L, White E, Prendergast GC. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 1995;11:2411-8.
14. Degenhardt K, Chen G, Lindsten T, White E. Bax and Bak mediate p53-independent suppression of tumorigenesis. Cancer Cell 2002;2:193-203.
15. Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006;10:51-64.
16. Nelson D, Tan T-T, Rabson AB, Anderson D, Degenhardt K, White E. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev 2004;18:2095-107.
17. Tan T-T, Degenhardt K, Nelson DA, et al. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 2005;7:227-38.
18. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005;5:675-88.
19. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002;111:29-40.
20. Debnath J, Muthuswamy S, Brugge J. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-68.
21. Weaver V, Bissell M. Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 1999;4:193-201.
22. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003;22:8590-607.
23. Cuconati A, White E. Viral homologues of Bcl-2: role of apoptosis in the regulation of virus infection. Genes Dev 2002;16:2465-78.
24. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 2003;17:2481-95.
25. Gelinas C, White E. BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev 2005;19:1263-8.
26. Puthalakath H, Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 2002;9:505-12.
27. Willis SN, Adams JM. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005;17:1-9.
28. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001;1:645-53.
29. Cuconati A, Mukherjee C, Perez D, White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 2003;17:2922-32.
30. Willis SN, Chen L, Dewson G, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005;19:1294-305.
31. Perez D, White E. TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol Cell 2000;6:53-63.
32. Wei MC, Lindsten T, Mootha VK, et al. tBid, a membrane-targeted death ligand, oligomerizes Bak to release cytochrome c. Genes Dev 2000;14:2060-71.
33. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-7.
34. Lindsten T, Ross AJ, King A, et al. The combined functions of the pro-apoptotic Bcl-2 family members, Bak and Bax, are essential for the normal development of multiple tissues. Mol Cell 2000;6:1389-99.
35. Vousden KH, Prives C. P53 and prognosis: new insights and further complexity. Cell 2005;120:7-10.
36. Chiou S-K, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994;14:2556-63.
37. Wei M, Zong W-X, Cheng E, et al. Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-30.
38. Zong W-X, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind prosurvival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001;15:1481-6.
39. Schwerk C, Prasad J, Degenhardt K, et al. ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol Cell Biol 2003;23:2981-90.
40. Cuconati A, Degenhardt K, Sundararajan R, Anschel A, White E. BAK and BAX function to limit adenovirus replication through apoptosis induction. J Virol 2002;76:4547-58.
41. Tan T-T, White E. Therapeutic targeting of death pathways in cancer. In: Khosravi-Far R, White E, editors. Programmed cell death in cancer progression and therapy. The Netherlands: Springer; 2006. In press.
42. Nelson D, White E. Exploiting different ways to die. Genes Dev 2004;18:1223-6.